CF
HRMY icon

Corebridge Financial’s Harmony Biosciences HRMY Stock Holding History

Corebridge Financial’s Portfolio HRMY Stock Details HRMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-19,906
Closed -$661K – 1250
2025
Q1 		$661K Sell
19,906
-390
-2% -$14K ﹤0.01% 1443
2024
Q4 		$698K Buy
20,296
+2,966
+17% +$102K ﹤0.01% 1503
2024
Q3 		$693K Sell
17,330
-254
-1% -$8.92K ﹤0.01% 1554
2024
Q2 		$531K Buy
+17,584
New +$529K ﹤0.01% 1663

Other funds holding HRMY

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VM
Valor Management Chicago, Illinois $181M AUM 6.67% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Corebridge Financial's HRMY Position: Q2 2025 in Review

Corebridge Financial sold out of Harmony Biosciences (HRMY) in Q2 2025, closing a stake of 19,906 shares — an estimated $661K sold.

Corebridge Financial first reported a position in HRMY in Q2 2024 and held it in 4 quarters. The position peaked at $698K in Q4 2024. 279 funds tracked by Wall St. Rank hold HRMY as of Q2 2025.

  • Corebridge Financial reported no remaining Harmony Biosciences position as of Q2 2025 after selling out during the quarter.
  • Corebridge Financial sold 19,906 Harmony Biosciences shares in Q2 2025, an estimated $661K.
  • Corebridge Financial first reported a position in Harmony Biosciences in Q2 2024 and held it in 4 quarters.
  • Corebridge Financial's Harmony Biosciences position peaked at $698K in Q4 2024.
  • 279 funds tracked by Wall St. Rank held Harmony Biosciences as of Q2 2025.

Based on Corebridge Financial's 13F filing for Q2 2025, filed 12 Aug 2025.